Photoinduced reduction of Pt(IV) within an anti-proliferative Pt(IV)-texaphyrin conjugate.

In an effort to increase the stability and control the platinum reactivity of platinum-texaphyrin conjugates, two Pt(IV) conjugates were designed, synthesized, and studied for their ability to form DNA adducts. They were also tested for their anti-proliferative effects using wild-type and platinum-resistant human ovarian cancer cell lines (A2780 and 2780CP, respectively). In comparison to an analogous first-generation Pt(II) chimera, one of the new conjugates provided increased stability in aqueous environments. Using a combination of (1) H NMR spectroscopy and FAAS (flameless atomic-absorption spectrometry), it was found that the Pt(IV) center within this conjugate undergoes photoinduced reduction to Pt(II) upon exposure to glass-filtered daylight, resulting in an entity that binds DNA in a controlled manner. Under conditions in which the Pt(IV) complex is reduced to the corresponding Pt(II) species, these new conjugates demonstrated potent anti-proliferative activity in both test ovarian cancer cell lines.

[1]  S. Yap,et al.  A fluorescent probe for investigating the activation of anticancer platinum(IV) prodrugs based on the cisplatin scaffold. , 2013, Angewandte Chemie.

[2]  P. Sadler,et al.  Diazido Mixed-Amine Platinum(IV) Anticancer Complexes Activatable by Visible-Light Form Novel DNA Adducts , 2013, Chemistry.

[3]  E. Yavin,et al.  Platinum(IV) prodrugs with haloacetato ligands in the axial positions can undergo hydrolysis under biologically relevant conditions. , 2013, Angewandte Chemie.

[4]  N. Margiotta,et al.  NMR investigation of the spontaneous thermal- and/or photoinduced reduction of trans dihydroxido Pt(IV) derivatives. , 2013, Inorganic chemistry.

[5]  E. Yavin,et al.  Cellular interactions of platinum drugs , 2012 .

[6]  E. Wexselblatt,et al.  What do we know about the reduction of Pt(IV) pro-drugs? , 2012, Journal of inorganic biochemistry.

[7]  X. Jing,et al.  A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy. , 2012, Chemical communications.

[8]  J. Sessler,et al.  A texaphyrin-oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells. , 2012, MedChemComm.

[9]  G. Natile,et al.  Dependence of the reduction products of platinum(IV) prodrugs upon the configuration of the substrate, bulk of the carrier ligands, and nature of the reducing agent. , 2012, Inorganic chemistry.

[10]  D. Kerwood,et al.  Pt(IV) complexes as prodrugs for cisplatin. , 2012, Journal of inorganic biochemistry.

[11]  X. Jing,et al.  Biodegradable polymer - cisplatin(IV) conjugate as a pro-drug of cisplatin(II). , 2011, Biomaterials.

[12]  J. Sessler,et al.  Overcoming biochemical pharmacologic mechanisms of platinum resistance with a texaphyrin-platinum conjugate. , 2011, Bioorganic & medicinal chemistry letters.

[13]  P. Sadler,et al.  A potent trans-diimine platinum anticancer complex photoactivated by visible light. , 2010, Angewandte Chemie.

[14]  K. Takrouri,et al.  New reduction pathways for ctc-[PtCl2(CH3CO2)2(NH3)(Am)] anticancer prodrugs. , 2010, Chemical communications.

[15]  Chad A Mirkin,et al.  Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads. , 2009, Journal of the American Chemical Society.

[16]  L. Kèlland,et al.  The resurgence of platinum-based cancer chemotherapy , 2007, Nature Reviews Cancer.

[17]  H. Dai,et al.  Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design. , 2007, Journal of the American Chemical Society.

[18]  M. Dolan,et al.  Molecular mechanisms of resistance and toxicity associated with platinating agents. , 2007, Cancer treatment reviews.

[19]  J. Sessler,et al.  Gadolinium texaphyrin-methotrexate conjugates. Towards improved cancer chemotherapeutic agents. , 2005, Organic & biomolecular chemistry.

[20]  M. Hall,et al.  Platinum(IV) antitumour compounds: their bioinorganic chemistry , 2002 .

[21]  M. Galanski,et al.  Reaction monitoring of platinum(II) complex--5'-guanosine monophosphate adduct formation by ion exchange liquid chromatography/electrospray ionization mass spectrometry. , 2001, Journal of mass spectrometry : JMS.

[22]  J A Koutcher,et al.  In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer. , 1999, International journal of radiation oncology, biology, physics.

[23]  P. J. Sadler,et al.  Platinierung von Nucleotiden, induziert durch sichtbares Licht , 1999 .

[24]  P. Sadler,et al.  Nucleotide Platination Induced by Visible Light. , 1999, Angewandte Chemie.

[25]  Sunhee Choi,et al.  Substitution and Reduction of Platinum(IV) Complexes by a Nucleotide, Guanosine 5'-Monophosphate. , 1999, Inorganic chemistry.

[26]  Sunhee Choi,et al.  Reduction and Anticancer Activity of Platinum(IV) Complexes , 1998 .

[27]  G. Lozano,et al.  Independent pathways of p53 induction by cisplatin and X-rays in a cisplatin-resistant ovarian tumor cell line. , 1998, Cancer research.

[28]  P. Sadler,et al.  [1H, 15N] NMR Investigations of Pt-NH Hydrogen Bonding in d(GpG), d(pGpG), and d(TpGpG)-N7,N7 Adducts of [Pt(en)]2+ in Aqueous Solution , 1994 .

[29]  J. Reedijk,et al.  Reaction of mer-trichloro (diethylenetriamine)platmum(IV) chloride, (mer-[Pt(dien)Cl3]Cl), with purine nucleosides and nucleotides results in formation of platinum(II) as well as platinum(IV) complexes , 1993 .

[30]  P. Sadler,et al.  Stereospecific hydrogen-bonding in mononucleotide adducts of platinum anticancer complexes in aqueous solution , 1993 .

[31]  Z. Siddik,et al.  Use of platinum as a modifier in the sensitive detection of tellurium in biological samples. , 1988, Analytical biochemistry.

[32]  Z. Siddik,et al.  Flameless atomic absorption spectrophotometric determination of platinum in tissues solubilized in hyamine hydroxide. , 1987, Analytical biochemistry.

[33]  A. Peters,et al.  Reaction products from platinum(IV) amine compounds and 5'-GMP are mainly bis(5'-GMP)platinum(II) amine adducts. , 1986, Journal of inorganic biochemistry.

[34]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.